A retrospective study conducted on a Chinese pan-cancer patient cohort revealed the presence of reversion mutations in three HRR-associated genes: BRCA1, BRCA2, and PALB2, across breast cancer, pancreatic cancer, OC, and lung cancer [13]. This evidence concerns the gene BRCA2 and familial pancreatic carcinoma.